Cite
HARVARD Citation
Osmon, K. et al. (n.d.). MG-110 Intravenous neonatal gene therapy corrects GM2 gangliosidoses in sandhoff mice for 'long-term', by using an aav expressing a new hexosaminidase variant. Journal of medical genetics. p. A4. [Online].